Et klinisk forsøg på en intensivafdeling, der behandler hyperglykæmi (blodglucose over 10 mmol/ l), med 204 diabetiske og 1344 ikke - diabetiske patienter, der gennemgik større kirurgiske indgreb, viste, at normoglykæmi (blodglucose 4, 4 – 6, 1 mmol/ l) induceret med intravenøs Actrapid reducerede mortaliteten med 42% (8% mod 4, 6%).
A clinical trial in a single intensive care unit treating hyperglycaemia (blood glucose above 10 mmol/ l) in 204 diabetic and 1344 non-diabetic patients undergoing major surgery showed that normoglycaemia (blood glucose 4.4 – 6.1 mmol/ l) induced by intravenous Actrapid reduced mortality by 42% (8% versus 4.6%).